Delivery Order SPE2DB22D3501-SPE2DB25FXC42
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of ORGOVYX 120 mg tablets in quantities of 30 units, with a ceiling value of $1,385.52 and a firm fixed price contract type. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award carries no set-aside designation,...
- The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $5,542.08 to AmerisourceBergen Drug Corp for the supply of ORGOVYX 120 mg tablets in quantities of 30 units. This competitive award, issued on July 24, 2025, with an ultimate completion date of August 14, 2025, utilizes firm fixed price pricing with no set-aside designation. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $1,385.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of ORGOVYX 120 mg tablets in quantities of 30 units. This is a non-set-aside competitive award with a completion date of August 29, 2025, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a...
- The Defense Logistics Agency has awarded a delivery order valued at $2,771.04 to AmerisourceBergen Drug Corp for the supply of ORGOVYX 120 mg tablets in quantities of 30. The contract, designated as non-competitive with a firm fixed price structure, is scheduled for completion by August 21, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. This delivery order operates as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of ORGOVYX 120 mg tablets (30-count units) with a ceiling value of $1,385.52. This firm fixed-price delivery order, which is not set-aside designated, is expected to be completed by August 28, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. This award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of ORGOVYX 120 mg tablets in quantities of 30 units. This $8,313.12 firm fixed price delivery order, with a completion date of September 8, 2025, is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was made on a competitive basis without set-aside designation and represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,385.52 delivery order to AmerisourceBergen Drug Corp for ORGOVYX 120 mg tablets (30-count units) with a firm fixed price arrangement. The award, issued on August 15, 2025, with an ultimate completion date of September 8, 2025, represents a competitively awarded, non-set-aside contract with performance to be executed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of ORGOVYX 120 mg tablets in quantities of 30 units, with a ceiling value of $1,385.52 and an ultimate completion date of September 9, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through...
- The Defense Logistics Agency awarded a $5.54K delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of ORGOVYX 120 mg tablets (30-unit package) with performance completion targeted for September 22, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the vendor's corporate headquarters in Conshohocken, Pennsylvania. The award represents a child delivery order issued under AmerisourceBergen's existing...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,385.52 for ORGOVYX 120 mg tablets (30-count units) on July 24, 2025, with an ultimate completion date of August 14, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. ORGOVYX is a prescription medication used in the treatment of prostate cancer, reflecting DLA's ongoing...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FXC42Delivery Order
The Defense Logistics Agency awarded a $5,542.08 delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of ORGOVYX 120 MG tablets in quantities of 30 units. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of September 22, 2025. ORGOVYX is a gonadotropin-releasing hormone receptor agonist used in the treatment of advanced prostate cancer, aligning with the DLA's comprehensive pharmaceutical support mission for military healthcare systems. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp maintains an extensive portfolio of delivery orders through the DLA Medical Supply Chain, supplying brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This award reflects the company's demonstrated capability to meet federal procurement requirements through open competition and its established role as a prime vendor supporting Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide. The contract includes no set-aside designation and was awarded under standard competitive procedures.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.5k | 8/29/25 |